This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_TESTIS_EXALLC for full statistics.
Malignant neoplasm of testis
C3_TESTIS
testicular carcinoma: A primary or metastatic malignant neoplasm that affects the testis. Representative examples include seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
613 |
4. Check minimum number of eventsNone |
613 |
5. Include endpointsNone |
613 |
6. Filter based on genotype QC (FinnGen only) |
613 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of testis
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of male genital organs
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 613 | - | 613 |
| Unadjusted period prevalence (%) | 0.27 | - | 0.27 |
| Median age at first event (years) | 36.23 | - | 36.23 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 566
- Matched controls
- 5659
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KFC00
NOMESCO Finland
Unilateral orchiectomy
1149.1
323.0
404
12
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
664.2
323.0
333
12
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
268.8
236
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
245.2
217
*
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
160.2
146
*
JN4BD
NOMESCO Finland
Extensive body CT
15.4
127.8
231
242
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
98.9
92
*
130
Kela drug reimbursment
Malignant tumour
14.4
98.0
178
175
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
18.3
97.6
158
117
A03FA01
ATC
metoclopramide; systemic, rectal
9.7
94.9
220
348
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
88.9
83
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
420.3
75.7
74
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
73.6
69
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
70.3
66
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.3
63.6
106
79
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
62.7
59
*
JN4AD
NOMESCO Finland
Body CT examination
10.9
61.6
125
143
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
59.1
334
1403
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
317.5
57.4
57
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
556.6
52.3
51
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
532.5
50.2
49
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
48.6
46
*
18699
ICD-8 Finland
Malignant neoplasm of testis
508.6
48.1
47
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
42.0
46.0
57
15
L03AA02
ATC
filgrastim; parenteral
22.2
45.7
67
34
A04AA02
ATC
granisetron; systemic, transdermal
12.8
45.3
83
75
121
Kela drug reimbursment
Severe hypofunction of sexual glands
27.3
36.5
50
20
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
380.4
36.4
36
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
35.8
34
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
35.8
34
*
JN3AD
NOMESCO Finland
Abdominal CT examination
6.6
34.9
96
171
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.5
34.4
111
241
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
33.7
32
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
33.7
32
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
32.6
31
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
32.4
242
1096
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
29.4
28
*
H02AB02
ATC
dexamethasone; systemic
6.3
28.8
81
147
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
26.3
26.9
37
15
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
26.2
25
*
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
24.1
23
*
A04AA01
ATC
ondansetron; systemic, rectal
6.6
24.1
64
107
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.5
24.1
91
230
L03AA13
ATC
pegfilgrastim; parenteral
21.2
23.3
34
17
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
23.1
22
*
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
23.1
22
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
20.0
22.9
34
18
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
47.1
22.5
27
6
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
21.1
181
843
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
21.0
20
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
21.0
20.6
30
15
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
12.7
20.3
36
30
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
12.8
19.8
35
29
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
19.7
106
360
D29.2
ICD-10 Finland
Benign neoplasm: Testis
47.8
19.3
23
5
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
15.5
19.1
31
21
N02BE01
ATC
paracetamol; systemic, rectal
2.6
19.1
459
3545
E29.1
ICD-10 Finland
Testicular hypofunction
9.6
18.7
38
42
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
7.4
17.5
42
61
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.0
17.2
39
52
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
16.7
16
*
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
5.4
16.7
51
102
Y78
ICPC
Malign neopl male genital other
174.9
16.6
17
*
WX320
NOMESCO Finland
Spinalanesthesy
2.7
16.3
128
554
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
15.7
15
*
DFF00
NOMESCO Finland
Pure tone audiometry
3.7
14.2
65
194
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
20.7
13.9
20
10
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.2
13.3
32
47
N02AA05
ATC
oxycodone; systemic
3.0
12.8
80
297
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
71.5
12.6
14
*
N46
ICD-10 Finland
Male infertility
5.7
12.6
36
67
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
12.5
12
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
132.8
12.5
13
*
Y05
ICPC
Scrotum/testis sympt/compl other
7.4
12.4
29
41
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.8
11.8
79
309
WX402
NOMESCO Finland
General anaesthesia
2.5
11.5
100
452
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
11.5
11
*
5703
FHL
Removal of lymph nodes from the retroperitoneal space
+∞
11.5
11
*
7513
FHL
Test prosthesis installation
122.4
11.5
12
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
11.3
72
271
KFA00
NOMESCO Finland
Exploration of testis
11.5
11.1
20
18
JN4CD
NOMESCO Finland
Very extensive body CT
5.7
11.0
31
57
ZX120
NOMESCO Finland
Intravenous
3.2
10.8
58
197
WZC30
NOMESCO Finland
Teaching
2.6
10.8
80
333
B01AB05
ATC
enoxaparin; parenteral
2.1
10.7
133
710
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
10.4
10
*
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
+∞
10.4
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
9.8
10.3
20
21
N05BA06
ATC
lorazepam; systemic, sublingual
4.2
10.1
38
96
WW500
NOMESCO Finland
Blood transfusion
5.1
9.9
30
61
KF8AE
SPAT
NA
7.3
9.6
22
31
A02BC02
ATC
pantoprazole; systemic
1.8
9.6
300
2217
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
101.7
9.4
10
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
101.7
9.4
10
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
8.2
9.4
20
25
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
9.4
9
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
14.0
9.2
15
11
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
37.3
9.0
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.3
8.9
26
51
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
8.7
94
473
KFB00
NOMESCO Finland
Biopsy of testis
28.0
8.5
11
*
B01AB10
ATC
tinzaparin; parenteral
3.5
8.5
38
113
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
11.0
8.3
15
14
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
14.7
8.2
13
9
R50.9
ICD-10 Finland
Fever, unspecified
2.2
8.2
86
425
KA1FN
NOMESCO Finland
Isotope renography
17.5
8.1
12
7
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
22.4
8.0
11
5
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
8.0
34
97
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.3
8.0
28
67
XX3DW
NOMESCO Finland
Time consuming IT work
2.7
7.9
53
205
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
7.3
7
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
1860B
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOP MAL TEST (ABD/ING),CA EMBR/TERATOCA/CHORIOCA]
+∞
7.3
7
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
7.3
7
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
7.2
46
175
M04AA01
ATC
allopurinol; systemic
2.3
7.2
69
327
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.1
7.2
37
123
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
6.7
7.2
17
26
Y28
ICPC
Limited function/disability (Y)
12.2
7.1
12
10
A04AD12
ATC
aprepitant; systemic
9.5
6.8
13
14
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
6.6
105
612
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.9
6.6
20
42
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
8.8
6.6
13
15
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
70.6
6.4
7
*
KFD43
NOMESCO Finland
Unilateral vasectomy or ligature of vas deferens
70.6
6.4
7
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
6.4
198
1410
KFC96
NOMESCO Finland
Other total excision of testis or epididymis
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
163
15
147.67
307.65
10.2
1.2
—
—
—
0
0
141
81
22.31
178.72
3.3
1.5
15.9
8.9
iu/l
3.31
121
62
183
206
12.24
156.71
3.0
1.5
7.3
4.5
u/l
4.85
162
175
277
845
5.16
86.94
4.1
2.3
13.4
14.8
nmol/l
2.18
264
778
429
2210
4.14
59.50
10.2
7.2
11.0
12.9
umol/l
4.24
424
2124
510
3361
4.08
40.81
12.7
8.2
76.2
78.1
u/l
0.56
501
3215
418
2581
2.95
34.31
12.5
10.6
3.6
4.1
e9/l
5.73
384
2277
240
1211
2.61
27.86
5.4
3.5
2.4
2.3
mmol/l
1.28
215
1088
60
142
4.58
23.80
1.4
3.1
171.3
193.9
%
1.00
60
136
148
635
2.75
23.22
5.9
3.4
2.4
2.4
mmol/l
0.04
131
558
211
1134
2.31
20.07
3.2
3.1
0.5
0.4
e6/l
0.14
169
860
289
1771
2.20
19.89
9.6
5.9
36.5
36.4
g/l
0.03
269
1662
287
1764
2.18
19.49
4.2
4.1
—
—
—
0
0
371
2544
2.16
18.73
5.8
5.4
6.7
6.8
mmol/l
0.69
357
2422
252
1494
2.17
18.53
3.4
3.2
—
—
—
0
0
299
1917
2.09
17.68
10.1
7.8
1.2
1.2
mmol/l
0.30
235
1656
273
1729
2.04
16.32
8.8
7.0
1.2
1.2
mmol/l
0.38
264
1600
191
1117
2.03
13.76
3.3
2.7
2337.9
5527.6
umol/l
0.70
177
999
529
4404
2.47
13.70
20.2
11.8
90.4
89.4
ml/min/173m2
0.44
485
3656
17
5
34.90
13.56
1.0
1.6
—
—
—
0
0
130
670
2.19
12.99
3.1
3.0
0.4
0.6
e6/l
0.44
83
373
134
700
2.17
12.94
3.0
2.8
0.9
1.0
e6/l
0.04
87
401
544
4636
2.54
12.50
22.8
15.1
139.4
139.7
mmol/l
1.97
534
4528
544
4658
2.49
11.97
23.3
15.2
4.0
4.0
mmol/l
0.56
533
4550
15
20
7.66
10.60
2.9
1.7
184.1
211.2
u/l
0.74
15
20
156
921
1.93
10.56
1.7
2.0
1.3
1.3
mg/l
0.01
119
659
539
4685
2.25
9.95
21.0
13.3
23.0
25.1
mg/l
0.84
455
3673
30
86
3.62
9.18
2.8
3.9
58.4
55.2
%
0.93
30
86
152
931
1.84
9.03
2.7
2.6
—
—
—
0
0
29
83
3.62
8.90
2.7
3.7
4.0
4.1
e9/l
0.06
29
83
12
7
17.45
8.10
6.3
5.0
0.4
0.3
umol/l
—
12
7
15
27
5.67
8.05
1.3
1.3
—
—
—
0
0
565
5099
2.38
8.00
15.0
9.8
32.8
33.9
u/l
0.74
560
4976
113
669
1.84
7.37
2.6
1.9
—
—
—
0
0
81
435
1.99
7.06
3.8
3.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
137
2.73
6.93
3.7
3.1
0.3
0.3
u/ml
0.39
19
69
15
32
4.78
6.72
2.1
1.6
0.1
0.2
nmol/l
0.20
15
23
459
3943
1.65
6.68
26.8
16.3
13.5
13.4
%
0.33
452
3860
26
88
3.04
6.18
2.0
2.1
—
—
—
0
0
33
137
2.49
5.39
6.7
7.0
861.5
439.8
iu/ml
—
6
17
59
312
1.99
5.38
2.1
1.6
—
—
—
0
0
30
119
2.60
5.37
2.1
2.0
—
—
—
0
0
30
120
2.58
5.28
2.1
2.0
—
—
—
0
0
52
266
2.04
5.20
1.7
1.4
—
—
—
0
0
63
350
1.89
4.98
5.9
5.1
4.5
47.6
ug/l
1.17
50
299
101
658
1.64
4.62
3.3
2.6
12.9
14.0
umol/l
0.72
94
625
246
1957
1.43
4.36
2.9
3.1
0.0
0.0
estimate
0.49
65
352
301
2492
1.41
4.21
4.2
4.0
1.8
1.9
ug/l
0.26
267
2272
244
1948
1.42
4.20
4.4
4.3
0.0
0.0
estimate
0.00
66
370
77
483
1.68
4.07
2.6
1.8
—
—
—
0
0
24
101
2.43
3.86
2.3
3.7
—
3115.9
—
0
9
69
432
1.67
3.68
5.2
4.1
1.4
1.6
mmol/l
0.20
58
349
243
1973
1.38
3.67
3.0
3.1
0.0
0.0
estimate
0.00
60
340
69
433
1.67
3.65
5.2
4.1
5.8
5.9
kpa
0.26
69
419
87
588
1.56
3.41
3.6
2.6
24.6
25.2
%
0.14
75
521
9
18
5.06
3.38
2.4
2.6
—
—
—
0
0
9
18
5.06
3.38
2.4
2.6
—
—
—
0
0
9
18
5.06
3.38
2.4
2.6
—
—
—
0
0
91
623
1.54
3.37
3.4
2.6
2.3
2.3
g/l
0.18
85
587
75
491
1.60
3.37
2.7
1.9
—
—
—
0
0
30
149
2.07
3.31
2.9
2.0
—
—
—
0
0
67
432
1.62
3.20
3.7
2.8
30.2
145.2
u/l
0.55
57
380
16
61
2.67
3.15
1.6
2.1
—
—
—
0
0
9
20
4.55
3.12
2.4
2.5
—
—
—
0
0
9
20
4.55
3.12
2.4
2.6
—
—
—
0
0
9
20
4.55
3.12
2.4
2.6
—
—
—
0
0
9
20
4.55
3.12
2.4
2.5
—
—
—
0
0
351
3083
1.32
2.93
4.0
3.9
11.7
9.7
mm/h
1.47
325
2899
79
543
1.52
2.88
5.5
3.3
12.7
10.9
umol/l
0.17
70
489
174
1383
1.36
2.88
3.5
2.9
52.4
57.0
u/l
1.49
161
1309
19
84
2.30
2.80
1.3
1.5
—
—
—
0
0
41
243
1.74
2.71
2.1
1.6
—
—
—
0
0
16
67
2.43
2.65
1.1
1.2
—
—
—
0
0
136
1058
1.37
2.56
3.2
3.3
1116.7
1437.9
ng/l
0.62
115
876
19
88
2.20
2.53
1.4
1.4
—
—
—
0
0
19
88
2.20
2.53
1.4
1.4
—
—
—
0
0
17
75
2.30
2.53
1.5
1.8
—
—
—
0
0
22
109
2.06
2.49
1.5
1.6
245.6
287.5
ug/g
0.29
12
66
9
26
3.50
2.49
1.3
1.2
—
—
—
0
0
9
26
3.50
2.49
1.3
1.2
—
—
—
0
0
9
26
3.50
2.49
1.3
1.2
—
—
—
0
0
9
26
3.50
2.49
1.3
1.2
—
—
—
0
0
9
26
3.50
2.49
1.3
1.2
—
—
—
0
0
14
57
2.49
2.46
2.4
2.1
—
—
—
0
0
45
283
1.64
2.42
3.2
3.3
127.8
134.0
g/l
0.82
45
276
19
90
2.15
2.41
2.5
2.6
130.5
133.0
g/l
0.10
11
69
5
8
6.29
2.37
1.0
1.1
—
—
—
0
0
190
1569
1.31
2.37
3.0
3.2
—
—
—
0
0
41
257
1.64
2.24
1.4
1.4
—
—
—
0
0
13
54
2.44
2.21
2.5
2.1
—
—
—
0
0
25
136
1.87
2.21
2.4
1.8
—
—
—
0
0
198
1663
1.28
2.14
3.9
3.4
54.3
46.3
ng/l
0.15
145
1104
56
383
1.51
2.13
2.4
2.1
374.4
366.1
nmol/l
0.14
51
355
114
890
1.35
2.09
2.5
2.1
2.9
3.0
mg/l
0.19
97
780
23
125
1.87
2.05
1.5
1.6
—
—
—
0
0
34
209
1.66
2.02
4.2
3.7
23.7
25.0
mmol/l
1.56
34
200
20
105
1.94
1.97
1.3
1.4
66.1
76.3
pmol/l
0.17
15
26
15
71
2.14
1.93
1.6
1.7
—
—
—
0
0
47
317
1.52
1.92
1.7
2.4
73.3
69.2
ml/min/173m2
0.18
18
127
7
23
3.07
1.80
1.3
1.9
—
—
—
0
0
83
633
1.36
1.78
2.0
1.7
1042.6
1188.5
nmol/l
0.91
59
507
18
95
1.92
1.77
1.5
1.8
—
—
—
0
0
19
103
1.87
1.73
1.4
1.7
—
—
—
0
0
8
30
2.69
1.73
1.3
1.8
—
—
—
0
0
7
24
2.94
1.72
1.3
1.9
—
—
—
0
0
11
48
2.32
1.71
1.1
1.0
—
—
—
0
0
65
481
1.39
1.68
3.8
4.2
28.3
28.9
%
0.16
50
363
43
294
1.50
1.68
3.5
3.2
0.7
1.7
mmol/l
1.25
33
216
70
528
1.37
1.62
10.4
9.6
0.6
0.8
mmol/l
0.21
58
422
15
77
1.97
1.60
1.6
1.7
—
—
—
0
0
30
191
1.60
1.60
2.2
3.4
5.1
4.8
pmol/l
0.41
25
175
13
64
2.05
1.55
1.1
1.1
—
—
—
0
0
50
359
1.43
1.54
4.7
3.0
5.4
4.7
kpa
1.14
50
345
10
44
2.29
1.54
2.5
2.0
—
—
—
0
0
10
44
2.29
1.54
2.5
2.0
—
—
—
0
0
10
44
2.29
1.54
2.5
2.0
—
—
—
0
0
9
38
2.39
1.46
4.0
2.3
—
—
—
0
0
9
38
2.39
1.46
1.3
2.0
—
—
—
0
0
168
1441
1.23
1.46
2.5
2.6
0.7
0.7
ug/l
0.18
109
822
28
180
1.58
1.45
6.8
7.8
1.7
1.7
%
0.02
28
166
33
221
1.52
1.44
3.3
2.7
0.1
0.2
e6/l
0.47
33
215
14
75
1.89
1.35
1.1
1.9
—
—
—
0
0
188
1645
1.21
1.33
5.0
3.9
37.6
37.2
u/l
0.03
181
1568
170
1479
1.21
1.27
1.9
1.8
91.9
94.4
pmol/l
0.28
97
845
457
4784
0.82
1.27
4.4
4.3
2.8
2.8
mmol/l
0.00
431
4494
58
444
1.34
1.26
11.8
10.8
121.2
125.8
g/l
0.85
58
426
8
36
2.24
1.24
1.6
1.7
1.2
1.0
g/l
—
8
36
18
108
1.69
1.23
1.1
1.3
568.0
549.0
mg/l
0.11
18
103
8
37
2.18
1.21
1.3
1.6
—
—
—
0
0
19
117
1.64
1.19
1.2
1.2
—
—
—
0
0
486
4654
1.21
1.16
24.4
13.5
41.1
42.4
%
2.50
387
3699
7
30
2.35
1.12
1.3
1.0
—
—
—
0
0
5
21
2.39
1.09
1.0
1.7
—
—
—
0
0
7
32
2.20
1.08
1.0
1.3
—
—
—
0
0
452
4714
0.84
1.06
4.0
3.9
1.2
1.3
mmol/l
1.56
423
4439
15
90
1.68
1.05
1.2
1.2
3.7
3.7
mmol/l
0.09
15
84
7
34
2.07
1.03
1.9
1.4
—
—
—
0
0
95
798
1.23
1.02
1.5
1.6
19.1
19.1
nmol/l
0.01
84
697
19
284
0.66
1.00
1.3
1.6
—
—
—
0
0
455
4735
0.85
1.00
4.1
4.0
4.6
4.6
mmol/l
0.23
428
4483
23
156
1.49
1.00
1.1
1.2
—
—
—
0
0
90
754
1.23
0.99
1.9
2.2
—
—
—
0
0
10
54
1.87
0.97
1.3
1.3
—
—
—
0
0
97
822
1.21
0.96
4.3
3.7
529.0
764.6
ng/l
0.40
76
621
14
85
1.66
0.95
1.1
1.5
—
—
—
0
0
7
37
1.90
0.94
1.9
2.1
—
—
—
0
0
12
70
1.73
0.93
1.2
1.1
—
—
—
0
0
12
70
1.73
0.93
2.6
1.4
7.7
4.3
u/ml
—
6
38
9
52
1.74
0.92
1.8
2.4
—
—
—
0
0
10
56
1.80
0.88
1.9
1.5
—
—
—
0
0
10
56
1.80
0.88
1.9
1.5
—
—
—
0
0
6
31
1.94
0.84
1.0
1.3
—
—
—
0
0
10
57
1.77
0.84
1.9
1.5
—
—
—
0
0
10
57
1.77
0.84
1.9
1.5
—
—
—
0
0
10
57
1.77
0.84
1.9
1.5
—
—
—
0
0
10
57
1.77
0.84
1.9
1.5
—
—
—
0
0
16
105
1.54
0.82
1.6
1.4
—
—
—
0
0
316
2969
1.13
0.82
3.2
2.9
14.9
14.9
pmol/l
0.10
286
2710
441
4576
0.87
0.80
3.6
3.6
1.5
1.4
mmol/l
1.05
410
4308
215
1974
1.14
0.79
3.4
3.6
22.2
21.3
%
0.31
87
771
81
690
1.20
0.78
1.9
2.1
—
—
—
0
0
9
53
1.71
0.75
1.1
1.0
—
—
—
0
0
5
24
2.09
0.74
8.0
2.8
—
—
—
0
0
85
981
0.84
0.73
1.3
1.2
4.9
1.4
u/ml
0.52
22
287
5
25
2.01
0.73
2.0
2.2
—
—
—
0
0
10
60
1.68
0.72
1.3
1.1
—
—
—
0
0
16
109
1.48
0.71
1.8
2.7
56.4
116.9
mg/l
0.48
11
85
16
109
1.48
0.71
1.9
2.7
46.5
38.9
mg/l
0.18
11
86
80
924
0.85
0.70
2.9
3.4
1.0
1.0
kg/l
0.07
13
114
7
41
1.72
0.70
1.1
1.0
—
—
—
0
0
7
41
1.72
0.70
1.0
1.1
272.9
285.5
mg/l
—
7
32
115
1021
1.16
0.69
3.1
3.4
0.0
0.0
estimate
0.27
62
342
21
155
1.37
0.63
1.1
1.2
253.2
271.1
u/ml
0.14
15
95
172
1582
1.12
0.61
3.6
2.6
192.3
190.9
ug/l
0.03
155
1485
8
51
1.58
0.60
3.5
4.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
20
0.00
0.60
0.0
2.2
—
130.5
—
0
20
42
507
0.82
0.60
1.2
1.2
3.3
9.5
u/ml
1.06
12
215
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
8
52
1.55
0.59
1.1
1.2
—
—
—
0
0
8
52
1.55
0.59
1.0
1.0
—
—
—
0
0
422
4359
0.90
0.59
4.2
3.9
6.0
6.0
mmol/l
0.16
385
4038
19
140
1.37
0.59
1.2
1.1
—
—
—
0
0
19
142
1.35
0.55
1.2
1.1
—
—
—
0
0
402
4155
0.91
0.54
5.6
5.2
39.6
39.7
mmol/mol
0.03
368
3941
6
38
1.58
0.54
1.7
1.6
—
1754683.3
—
0
6
20
152
1.33
0.52
1.5
1.8
—
—
—
0
0
16
118
1.37
0.50
3.7
2.3
25.3
24.6
mmol/l
0.39
16
108
49
570
0.85
0.49
1.1
1.2
15.0
28.1
iu/ml
2.03
13
174
7
45
1.56
0.49
1.1
1.0
—
—
—
0
0
122
1117
1.12
0.48
1.8
1.7
1.6
1.6
mmol/l
0.11
99
966
395
3828
1.09
0.45
3.8
3.5
1.8
2.2
mu/l
0.61
357
3532
30
247
1.23
0.45
7.5
5.0
135.2
95.7
ng/l
1.25
25
225
91
1002
0.89
0.44
1.7
2.1
1.5
1.5
%
0.00
86
919
16
122
1.32
0.42
2.0
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
5
34
1.47
0.40
2.0
1.5
325.6
313.9
u/l
—
5
34
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
20
161
1.25
0.37
2.3
3.7
—
—
—
0
0
22
182
1.22
0.33
3.3
2.9
—
—
—
0
0
10
75
1.34
0.30
1.2
1.1
—
—
—
0
0
14
111
1.27
0.30
1.1
1.4
—
—
—
0
0
7
56
1.25
0.29
1.1
1.1
242.6
271.3
mg/l
—
7
51
9
75
1.20
0.25
1.9
1.7
0.0
0.0
g/l
—
9
68
9
76
1.19
0.24
1.9
1.7
0.0
0.0
g/l
—
9
68
16
133
1.21
0.24
1.1
1.3
—
—
—
0
0
51
466
1.10
0.24
8.5
7.0
—
—
—
0
0
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
25
219
1.15
0.22
3.4
2.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.3
—
83.4
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
8
101
0.79
0.21
1.3
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
83
782
1.07
0.20
1.7
1.7
435.9
5908834.3
pmol/l
0.50
65
677
27
240
1.13
0.20
1.3
1.2
—
—
—
0
0
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
16
186
0.86
0.19
1.5
1.7
—
260.0
—
0
5
370
3645
1.04
0.16
3.8
3.3
61.2
52.4
u/l
0.80
356
3488
8
73
1.10
0.15
1.5
1.2
—
—
—
0
0
59
625
0.94
0.15
1.7
1.7
—
—
—
0
0
14
123
1.14
0.12
1.1
1.6
—
—
—
0
0
14
158
0.88
0.12
1.1
1.3
243.7
176.6
miu/ml
—
7
67
54
514
1.06
0.11
31.4
22.4
1.3
1.3
inr
—
10
71
12
105
1.15
0.11
1.8
1.7
9.1
11.1
g/l
1.99
12
88
21
228
0.92
0.10
1.0
1.1
—
—
—
0
0
5
44
1.14
0.10
3.2
2.8
635.2
500.5
e6/l
—
5
39
14
155
0.90
0.09
2.1
2.2
13.0
11.7
mg/l
0.24
14
143
6
57
1.05
0.08
1.7
1.2
—
—
—
0
0
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
139
1416
0.98
0.07
3.1
3.8
9.5
9.2
mmol/l
0.23
113
1213
126
1235
1.03
0.07
4.1
4.3
10.5
12.0
mg/mmol
0.14
80
854
9
84
1.07
0.07
1.0
1.1
—
—
—
0
0
8
94
0.85
0.06
1.0
1.2
12.0
50.0
u/l
—
8
84
10
90
1.11
0.05
1.8
1.8
0.0
0.0
g/l
—
10
82
96
979
0.98
0.05
1.5
1.4
—
—
—
0
0
153
1510
1.02
0.05
2.6
2.3
72.7
71.6
nmol/l
0.17
137
1396
13
120
1.09
0.05
1.6
1.8
—
—
—
0
0
10
91
1.10
0.04
1.8
1.6
37.6
37.7
g/l
—
10
73
26
271
0.96
0.04
9.5
8.9
24.1
24.1
mmol/l
0.01
26
252
13
137
0.95
0.01
2.0
2.4
75.6
117.6
ug/min
—
8
76
24
233
1.03
0.01
2.4
2.1
43.7
39.7
u/l
0.27
19
212
12
126
0.95
0.00
5.1
1.4
1.3
1.1
g/l
0.69
12
121
13
126
1.03
0.00
1.0
1.2
—
—
—
0
0
12
123
0.98
0.00
5.1
1.3
0.3
0.2
g/l
0.38
12
117
358
3578
1.00
0.00
2.9
3.1
—
—
—
0
0
0
5
0.00
0.00
0.0
5.0
—
458.6
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
3.1
—
0
5
7
76
0.92
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
0.00
1.2
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
0.00
2.0
6.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_TESTIS – Malignant neoplasm of testis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).